Skip to main content

Market Overview

22 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Nabriva Therapeutics, Inc. (NASDAQ: NBRV) stock moved upwards by 24.9% to $2.76 during Tuesday's pre-market session. The market value of their outstanding shares is at $176.8 million.
  • Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) shares moved upwards by 22.8% to $0.58. The market cap seems to be at $19.6 million.
  • VIVUS, Inc. (NASDAQ: VVUS) shares moved upwards by 22.6% to $4.17. The market cap seems to be at $23.7 million.
  • Soliton, Inc. (NASDAQ: SOLY) shares increased by 13.0% to $12.50.
  • Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) stock increased by 9.7% to $1.02.
  • Restoration Robotics, Inc. (NASDAQ: HAIR) stock surged 8.0% to $0.74. The market cap stands at $22.8 million.
  • Moleculin Biotech, Inc. (NASDAQ: MBRX) stock increased by 7.0% to $1.23.
  • Medtronic, Inc. (NYSE: MDT) stock surged 4.4% to $108.75. The most recent rating by Deutsche Bank, on August 19, is at Buy, with a price target of $111.00.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) stock moved upwards by 4.1% to $2.04.
  • Canopy Growth, Inc. (NYSE: CGC) stock moved upwards by 4.0% to $27.80. The most recent rating by Ladenburg Thalmann, on July 17, is at Buy, with a price target of $50.00.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) shares increased by 3.4% to $6.15. The most recent rating by Bank of America, on August 13, is at Neutral, with a price target of $7.00.
  • Acasti Pharma, Inc. (NASDAQ: ACST) shares increased by 2.2% to $1.83. The most recent rating by Oppenheimer, on July 18, is at Outperform, with a price target of $7.00.

 

Losers

  • Synlogic, Inc. (NASDAQ: SYBX) shares plummeted 20.9% to $3.82 during Tuesday's pre-market session.
  • NuCana, Inc. (NASDAQ: NCNA) stock plummeted 20.5% to $5.82. The market value of their outstanding shares is at $290.1 million. The most recent rating by H.C. Wainwright, on August 19, is at Buy, with a price target of $20.00.
  • Sarepta Therapeutics, Inc. (NASDAQ: SRPT) shares fell 16.6% to $100.30. The most recent rating by Janney Capital, on August 20, is at Buy, with a price target of $175.00.
  • Gemphire Therapeutics, Inc. (NASDAQ: GEMP) stock fell 10.8% to $0.50. The market cap stands at $101.9 million.
  • Miragen Therapeutics, Inc. (NASDAQ: MGEN) shares plummeted 8.1% to $1.25. The most recent rating by H.C. Wainwright, on August 19, is at Buy, with a price target of $3.00.
  • TrovaGene, Inc. (NASDAQ: TROV) shares decreased by 8.0% to $2.76.
  • Plus Therapeutics, Inc. (NASDAQ: PSTV) shares decreased by 6.9% to $8.38. The market value of their outstanding shares is at $226.6 million.
  • Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) stock fell 6.0% to $2.35.
  • Elanco Animal Health, Inc. (NYSE: ELAN) stock declined 6.0% to $28.00. The market cap stands at $11.5 billion. The most recent rating by UBS, on August 15, is at Neutral, with a price target of $30.00.
  • SELLAS Life Sciences, Inc. (NASDAQ: SLS) shares decreased by 3.2% to $0.15. The market value of their outstanding shares is at $27.0 million.
 

Related Articles (ACST + BLCM)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com